Since two other IPF drugs, Pirfenidone and Nintedanib, have been shown to reduce the fibular arrangement of α-SMA in IPF fibroblasts and thereby reduced the generation of myo-fibroblasts transformation36 a similar action may be achieved by Treprostinil. Here, ACTA1 is linked to idiopathic pulmonary fibrosis.